Ryo Amagai

8PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersMolecular targetsAllergyCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 03, 2026
Cutaneous Squamous Cell Carcinoma Arising From Hidradenitis Suppurativa and Epidermal Cyst: Clinical Characteristics, Baseline Neutrophil-To-Lymphocyte Ratio, and Disease-Specific Survival in a Retrospective Cohort.

|Mar 25, 2025
Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment.

Ryo Amagai, Taku Fujimura, Yumi Kambayashi

|Feb 26, 2025
An Evaluation of Prognostic Factors in Cutaneous Squamous Cell Carcinoma: A Single-Center Study of 237 Japanese Cases.

Emi Yamazaki, Taku Fujimura, Manami Takahashi-Watanabe

|Jan 25, 2025
Impact of Hyaluronic Acid on the Cutaneous T-Cell Lymphoma Microenvironment: A Novel Anti-Tumor Mechanism of Bexarotene.

Tetsuya Ikawa, Emi Yamazaki, Ryo Amagai

|Apr 17, 2024
Radiation-induced cutaneous squamous cell carcinoma showing a significant response to pembrolizumab: A case report.

Manami Takahashi-Watanabe, Taku Fujimura, Ryo Amagai

|Dec 19, 2023
Vogt-Koyanagi-Harada disease-like uveitis after drug therapy including BRAF/MEK inhibitors in melanoma patients with HLA-DRB1*04.

Ryo Amagai, Taku Fujimura, Emi Yamazaki

Pageof 2

Frequent Collaborators

7 joint publications

Taku Fujimura

6 joint publications

Yoshihide Asano

5 joint publications

Yumi Kambayashi

5 joint publications

Emi Yamazaki